Clinical trial
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
NCT05764005 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 9, 2022
- Completion date
- March 11, 2024
- Enrollment
- 39 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer